MEDIA COVERAGE
The Enzymatic Edge: Rewriting the Future of DNA Synthesis
December 23, 2026In this latest Technology Networks article, explore how DNA Script and its enzymatic DNA synthesis technology are reshaping mRNA therapeutic …
▶
▶
MEDIA COVERAGE
Novel enzymatic DNA produced from a text file achieves comparable immune responses as plasmid vaccine
December 13, 2026This new study, published in npj vaccines demonstrates that DNA oligos synthesized enzymatically, with the SYNTAX® platform, from a digital …
▶
▶
MEDIA COVERAGE
Is outsourced oligo supply slowing down your gene synthesis work?
December 11, 2026Many teams rely on external vendors for oligo synthesis and accept variable lead times, shipment delays, and limited visibility into …
▶
▶
PRESS RELEASE
Pushing mRNA vaccine development timelines to new speeds
February 6, 20256 February 2025; OSLO; PARIS: Scientists in Paris are set to advance new technology that could streamline the production of …
▶
▶
MEDIA COVERAGE
Africa and Europe Join Forces to Revolutionize RNA-based Vaccines and Therapeutics Production: MoU Signed Between EVA Pharma, DNA Script, Quantoom Biosciences
February 5, 2025CAIRO, Egypt – February 5, 2025 – Africa’s EVA Pharma, France’s DNA Script, and Belgium’s Quantoom Biosciences have signed a …
▶
▶
MEDIA COVERAGE
DNA Script Breaks Length and Complexity Barriers With New Enzymatic DNA Synthesis Offering
January 30, 2025The new offering delivers exceptional sequence versatility, accommodating challenging compositions including high GC content, poly-A, poly-T, Inverted Terminal Repeat (ITR), …
▶
▶
MEDIA COVERAGE
DNA Script Appoints Marc Montserrat as CEO to Drive Long-Term Commercial Growth for Groundbreaking Enzymatic DNA Synthesis Platform
October 17, 2024Founding CEO Thomas Ybert transitions to Chief Scientific Officer role to underscore company’s ongoing commitment to scientific discovery and innovation PARIS and DALY CITY, Calif. – DNA Script, a leader in enzymatic DNA synthesis, …
▶
▶
PRESS RELEASE
DNA Script to Unveil Industry’s Most Versatile On-site, On-Demand DNA Printer at the World’s Largest Synthetic Biology Conference
May 22, 2023Fully automated SYNTAX platform features latest STX-200 system, enzymatic biochemistry advances, and ready-to-use reagents for producing up to 96 oligos …
▶
▶
MEDIA COVERAGE
DNA Writing Goes Enzymatic, Encourages Pursuit of Bold Visions
December 7, 2022The gold standard for DNA writing, phosphoramidite chemistry, is being challenged by a new method, enzymatic synthesis …
▶
▶
MEDIA COVERAGE
Deeptech Sees Big
November 28, 2022Last October, Bpifrance organized the second edition of Deeptech Sees Big, a highly anticipated event that brought together many students, …
▶
▶
NEWSLETTER
The Transcript, November 2022
November 17, 2022This enewsletter edition highlights our upcoming webinar on accelerated gene fragment assembly EDS, a recent Nature Communication publication by UQ …
▶
▶
PRESS RELEASE
DNA Script Strengthens Its Management Team with the Appointment of Bruno Poddevin as Senior Vice President of Business and Corporate Development
November 9, 2022Poddevin joins DNA Script in a year of immense growth in hiring, financing, commercialization and collaborations. DNA Script, a world …
▶
▶
MEDIA COVERAGE
Biotech Breakthrough 2022 Award Winners
November 3, 2022DNA Script selected as “Overall MedTech Company of the Year” for the Biotech Breakthrough 2022 Awards! …
▶
▶
MEDIA COVERAGE
Europe’s Deeptech ‘Soonicorns’
October 24, 2022(Subscription required) These are the deeptech startups most likely to become unicorns soon. …
▶
▶
MEDIA COVERAGE
Why Good Research Doesn’t Need To Take A Long Time
October 24, 2022Biomedical research takes time—usually not months but, instead, years and sometimes even decades. It’s been programmed into all our expectations …
▶
▶
